Vancouver, Bc–(Newsfile Corp. – April 21, 2017) – Canabo Medical (TSXV: CMM) (OTCQB: CAMDF) has opened up a brand new clinic in Kelowna, Bc. Canabo wholly operates and owns Cannabinoid Medical Clinics, or CMClinics, Canada’s largest physician brought referral-only clinics for medical cannabis.
InvestmentPitch.com has created a “video” which discusses what is the news. If the link isn’t enabled, check out www.InvestmentPitch.com and enter “Canabo” within the search engine. The recording can also be on YouTube.
Cannot view this video? Visit:
http://www.investmentpitch.com/video/_szpes969/Canabo-Medical-TSXV-CMM-opened up-a-new-clinic-in-Kelowna-British-Columbia
The brand new clinic, found in the Sterling Center at 3975 Lakeshore Road, is going to be brought by Dr. Chemanthi Kalen.
Established in 2014, Canabo presently has 16 corporate clinics across Canada with intends to open several additional corporate clinics in 2017.
Because of high patient demand, the organization also announced the outlet of the second Peak Medical Group location in Edmonton. The Height Medical Group operates partner clinics throughout Alberta.
Dr. Neil Cruz, Executive Chairman, mentioned: “Kelowna marks the sixth clinic opening for Canabo in 2017 and demonstrates we’re ongoing to complete on the aggressive clinic unveil schedule. We’re also happy with our patient development in Alberta through our partner Peak Medical.”
Canabo operates referral-only medical clinics focused on evaluating the appropriateness of prescribing, and monitoring cannabinoid treating patients struggling with chronic discomfort and disabling illnesses. Clinics are staffed by physicians and qualified health care professionals particularly educated to assess patient appropriateness for cannabinoid treatment, recommend treatment regimes, and monitor treatment progress.
A study by Canacccord Genuity mentioned: “We feel elevated convenience, education around the therapeutic advantages of cannabis, and home loan business the historic stigma connected with marijuana use has led to a clinical patient base in Canada that’s presently more than 100,000 patients — a substantial uptake from merely a couple of 1000 registrants a few years ago. Further, we feel this patient is made of set to greater than quadruple within the next 5 years. We estimate that by 2021 you will see ~500,000 registered patients in Canada who depend on cannabis like a medical care.”
Canaccord Genuity further estimates that by 2021, the medical segment of the profession will consume greater than 150,000 kilograms of cannabis yearly.
Canabo lately partnered having a consortium of scientific research experts to evaluate data from greater than 1,500 patients for the exact purpose of focusing on how cannabis interacts with or lessens the requirement for pharmaceutical treatments. The landmark study demonstrated a clear, crisp stop by benzodiazepine reliance among Canadian patients which were under physician-supervised medical cannabis treatments.
Benzodiazepines, generally offered under names for example Valium and Xanax, are utilized by 10 percent from the general population in Canada. Research conducted in the last year says 40 percent of patients who have been prescribed medical cannabis to deal with discomfort and anxiety eliminated using benzodiazepines within 3 months, several that increased to 45 percent inside a year of cannabis treatment.
To learn more check out the business’s website www.canabocorp.com, or contact Madeline Whittaker at 902-334-1700 or email media@cmclinic.ca.
About InvestmentPitch Media
Investmentpitch Media leverages the strength of video, which along with its extensive distribution, positions a company’s story in front of the 1,000’s of companies seeking awareness and funding in the financial community. The organization focuses on producing short videos according to significant news releases, research reports along with other content of great interest to investors.
CONTACT:
InvestmentPitch Media
Craig Morgan, CFO
bmorgan@investmentpitch.com
Resourse: http://newsfilecorp.com/release/26278/
